{
    "Trade/Device Name(s)": [
        "FDI Glucose Control for Aviva",
        "FDI Glucose Control Solution for Aviva"
    ],
    "Submitter Information": "Fujirebio Diagnostics, Inc.",
    "510(k) Number": "K110436",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043474"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "February 8, 2011",
    "Summary Letter Received Date": "February 15, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "single (specified) analyte controls (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [
        "Plastic bottle with dropper-tip"
    ],
    "Instrument(s)/Platform(s)": [
        "Accu-CHEK Aviva Blood Glucose Monitor",
        "Accu-CHEK Aviva Blood Glucose System"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for FDI Glucose Control for Aviva, an assayed control solution for verifying Accu-CHEK Aviva glucose monitor performance",
    "Indications for Use Summary": "For in vitro diagnostic use by healthcare professionals and at home by people with diabetes mellitus to assess the performance of the Accu-CHEK Aviva Blood Glucose Monitor",
    "fda_folder": "Clinical Chemistry"
}